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IV. SUMMARY 
V. REFERENCES 
RATIONALE 
Solid dosage forms play a major role in the practice of medication. Research on the factors 
influencing the manufacturing of solid forms of medicines are therefore of great importance. In 
the process of tablet making, for example, the chemical and physical properties of the active agent 
must be taken into consideration. The natures and amounts of auxiliary materials and the 
procedures applied must be chosen in accordance with the characteristics of the active component 
so that the latter undergoes no unwanted alterations during manufacturing. 
A number of methods are available in tablet making. One possibility is direct compression. A 
powder mixture intended for direct compression should be of adequate fluidity and 
compressibility [1], These features can be influenced by the powder flow properties of drugs. 
Numerous materials, however, have unsuitable flow properties and compressibility and hence 
require wet granulation prior to tabletting. During this process, the quality of the granules is 
influenced by the granulating fluid. Furthermore, the parameters of the granules influence the 
quality of the resulting tablets. The preparation of tablets with a high active agent content is 
particularly difficult. The aim here is not to increase the weight of the tablets during tablet 
making. The only way to achieve this is to use the smallest amount of excipients. 
Kneading is one means of wet granulation. Afler homogenization of the components, the powder 
mixture is kneaded with a granulating solution. The wet mass is then passed through a sieve and 
the granules are dried [2-5]. 
Wet granulation can also be performed by the fluidization process. In a fluid bed apparatus, the 
particles are floated upwards from below by the introduction of air at high pressure. The 
granulating solution is sprayed in from above. The particles can in this way stick together; fluid 
bridges are formed, which will become solid bridges during drying [6-10]. 
The model substance chosen for the present experimental work was metronidazole. Its oral 
therapeutic dose is 250 mg; metronidazole tablets therefore belong among tablets with a high 
active agent content. The aim of my work was to produce a tablet with optimal parameters by 
using a variety of auxiliaries. The morphology of the agent was studied and the particle size 
distribution, powder flowability and water absorption of the granulates produced were 
determined. I also investigated the physical parameters of the tablets made, and additionally the 
extent and rate of drug liberation from the tablets, including a mathematical description of the 
drug liberation process. 
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I. INTRODUCTION 
In pharmaceutical production, granulation is primarily a preparatory step of tabletting, permitting 
alteration of the characteristics of powders unfavourable for tablet compression. For compression, 
good flowability, adequate particle size distribution, optimal compactibility and nearly 
isodimensional particle shape are of great importance. 
In dry granulation, the components are dry-mixed and then compressed, a process called 
briqueting. The briquets are then chopped in a suitable device and particles of the desired size are 
separated by a sieve. The four steps of dry granulation are homogenization, compression, 
chopping and sieving. It is important in the chopping of the briquets to obtain granules in the 
determined size range and no excessive amount of dust [11]. 
In wet granulation, the powder mixture containing the active agent is wetted with a solution 
containing a binding agent. During the procedure, fluid bridges are formed between the particles. 
In the course of the subsequent drying, the solvent evaporates and solid bridges are formed in 
parallel with the reduction of the surface and the agglomeration of the particles. [2]. 
In conventional granulation (granulation by kneading), the prepared powder mixture is 
homogenized and subsequently aggregated with the granulation fluid. The wet mass obtained is 
dispersed through a sieve or a perforated plate. The process can be achieved in practice with the 
Z-arm kneading machines, oscillating granulators, etc. 
Fluidization granulation [12] involves wetting, granule formation and drying in one apparatus. 
The granulation step itself is achieved in the lower, conical part of the apparatus, called the bulk 
container. The particles are kept moving by the compressed air introduced into the device. 
Powder particles move upwards with the air stream in the column and meet the droplets of the 
sprayed binding agent. The surface of the particles is thus partially moistened. Fluid bridges are 
formed between the particles, which are transformed into solid bridges by the simultaneous 
drying. This is the way the granulate is built up. In the procedure, care must be taken with 
materials that tend to adhere or aggregate or have bad wetting properties, because they are 
floated unevenly, resulting in over-moistened clumps. Granulates obtained by fluidization usually 
have a smaller particle size and a more homogeneous size distribution than those produced by the 
traditional methods. The fine powder content of the granules is lower. The units obtained are 
nearly spherical and their surface is a little rough. Such particles are tabletted with no problem. 
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In rotational or vortex granulation [13], the dust mixture is first homogenized in the vortex 
apparatus. The granulating fluid is then applied by spraying. The moistened dust particles 
agglomerate due to the swirling rotation and in this way the granules are gradually built up. The 
process can be continued until the desired particle size is achieved. 
Vacuum granulation [14] allows the performance of five steps (homogenization, kneading, 
granulation, drying and regranulation) in one device. Homogenization is followed by applying the 
granulation fluid. The wetted particles adhere to each other: granules are formed. At the same 
time, chopper knives perform the regranulation. 
Tablets as solid dosage forms must have a declared active agent content, an appropriate 
disintegration time, the necessary mechanical resistance, appropriate drug liberation, an attractive 
appearance, etc. Tablet production involves not only the active constituents, but usually a 
variety of auxiliary substances, as the number of agents compressible to tablets without addition 
of an auxiliary is limited [15-17], In the application of auxiliaries, the primary requirement is to 
obtain tablets with uniform mass, adequate mechanical resistance, and properties corresponding to 
a good biological utilization of the drug. The auxiliaries can be fillers, binders, adsorptives, 
moisture stabilizers, disintegrants, hydrophilizers and dissolution retardants. Glidants, lubricants, 
antiadhesives, antistatics, sweetenings and colorings are also used [18-30], 
Tablets are manufactured in tabletting machines. The main parts of these are the upper and lower 
punches, the die, the feeder and the filling funnel. The adequately prepared powder mixture or 
granulate is introduced into the cavity of the die. During compression, the evenly increasing force 
exerted by the upper punch (or both punches) constrains the particles to undergo plastic or elastic 
deformation. During the compression, the particles first slide along each other and fill up the 
space available, and are then deformed, resulting in ready pressing, i.e. the tablets are held 
together by direct and indirect (electrostatic, etc.) bonds [31,32], 
Flowability can be defined as the ease of flow of the powder mass as a whole [33], Numerous 
factors affect the flow properties of powders, e.g. particle shape and size, size distribution, 
surface roughness of the particles and compacting properties [34], Several methods can be used 
to investigate flow properties. The angle of repose has been widely used [35] as a flow parameter. 
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Angle of repose (°) Flow properties 
<25 very good (excellent) 
25-30 good 
30-40 fair to passable 
>40 very poor 
Values of 40-45° are often taken as the dividing line between poor flow and good flow [33], The 
experimental conditions applied during testing have a great influence on the results [36]. 
Measurement of the time required for a certain amount of powder mass to flow through a funnel 
is another method widely utilized [35] to describe powder flow. Numerous findings, however, 
show that this time or flow rate is usually not correlated with the flow of powder in the tabletting 
process [37], Flowability can also be measured by using a recording powder flowmeter [38] or 
tensile testers and shear cells [36]. 
The results from the tapping test are likewise widely employed [35, 38, 39] as flow parameters. 
The shape, size, size distribution and surface roughness of the particles, and the amplitude and 
frequency of beats directed towards the powder bed, affect the density of the powder during the 
tapping test [37,40], 
Carr s index [41] can be calculated according to the equation : 
Carr< s index <%) = tapped density - loose density ^ lQQ (1) 
tapped density 
Carr's index characterizes the flow property as follows [42,43]: 
Carr's index Flow description 
5-15 excellent 
12-16 good 
18-21 fair to passable 
23-35 poor 
33-38 very poor 
>40 extremely poor 
Hausner demonstrated that a ratio between the tapped density and the loose density of 
approximately 1.2 was characteristic of powders with low interparticle friction, such as coarse 
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spheres, while a ratio of more than 1.6 corresponded to more cohesive and less free-flowing 
powders, such as flakes. The Hausner ratio is calculated as follows [1]: 
Hausner factor = taPPedd^mity (2) 
loose density 
The rearrangement constant is another parameter for compactibility evaluation. Here, the first 
step during the formation of a tablet is filling, and the next is rearrangement. If this is insufficiently 
fast, a "hole" can form in the tablet and this can lead to lamination or capping. These phases 
influence the compactibility [44], The extent of particle rearrangement is a function of the surface 
structure, particle size and shape. The force applied must overcome the interparticle friction and 
cohesion before slippage and rearrangement of the particles can take place [45], The 
rearrangement constant (k) can be calculated from the loose and tapped volume data according to 
Takkiedin [46] : 
= (! + &,)-*» (3) 
* 0 ' 00 
where n = number of taps, 
Vn = powder volume after n taps, 
V0 = initial powder volume, 
Vm = final powder volume. 
The rearrangement constant (&) is the slope of the curve from linear and exponential regression 
analysis. 
Some authors [35, 47] have applied the Kawakita equation to tap density measurements by using 
the formula 
N N 1 
— = —+ — (4) 
C a ab 
where N is a tapping number, 1 la is a constant related to the volume reduction, called the 
compactibility, and lib is another constant, related to cohesion and called the cohesiveness [39, 
48]. 
The ability of a powder mass to reduce in volume when compressed does not ensure the 
formation of a tablet [49]. For the industrial-scale production of tablets, it is much more important 
to obtain tablets with adequate strength rather than adequate deformation and volume reduction 
mechanisms [50], 
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Postcompression parameters are widely used to evaluate the compactibility and compressibility of 
a variety of pharmaceutical materials by measuring tablet mass variation and the mechanical 
strength, which can be described by several means, including the crushing strength [51], the axial 
or radial tensile strength [52], the breaking hardness [53] and the friability [54, 55], The 
disintegration time [56, 57] and the dissolution time [57, 58] are also very important parameters 
to evaluate tablet quality. 
One of the most important postcompression parameters is the breaking hardness. During breaking 
hardness determination, a vertically or horizontally fixed tablet is exposed to a gradually 
increasing load along its diameter. A shear effect develops in the tablet, which results in splitting 
in the mid-line, i.e. the tablet breaks [42, 59-61], 
Various methods and instruments are applied for the measurement of breaking strength, but most 
literature reports merely present hardness values and do not describe the deformation process 
leading to breaking. Schweiger and Zimmermann described a tensile strength tester and methods 
for measurement of the tensile strength of powders [62], During the past few years, a number of 
hardness testers have become available, with which the breaking curves of tablets can be 
recorded. 
In the present work, the process of breaking of metronidazole tablets was studied by means of a 
modified breaking hardness tester. The tester is connected to a computer via an interface. The 
breaking process can be analysed by means of appropriate software, which yields not only the 
hardness value, but also the work necessary for breaking. Accordingly, it is possible to investigate 
the deformability of the tablets. 
The hardness of tablets obtained by wet granulation is also influenced by the properties of the 
macromolecular film formed by the binding agent used, and therefore the deformability of the film 
must be taken into consideration. This has a decisive role in the elastic recovery phase of the 
compression. If the film is of adequate elasticity, it will not break and retains its stability-
increasing role. A film of lower elasticity will break apart, however, which can afreet the hardness 
of the tablet. The formation and study of free films have been extensively described in the 
literature [63-76], 
Free films are obtained in several ways. Numerous authors have used casting or spray application 
on a Teflon surface. Others have developed casting on a mercury surface, or sprayed the coating 
agent on a rotating disk, from which the film was released by use of an appropriate knife. 
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It is very important to study the rate of drug dissolution from tablets and to evaluate the results 
mathematically. There are many papers on the mathematical evaluation of drug liberation [77, 78]. 
The results concerning the rate of dissolution of metronidazole were evaluated by means of the 
Rosin-Rammler-Sperling-Bennett-Weibull (RRSBW) distribution, and the characteristic 
dissolution time (t63.2%) was determined after linearized regression and transformation by 
Langenbucher according to the following equation [79-86]: 
M = MA 1 - exp U - T Y 
a (5) 
where M is the amount of material dissolved after time t, Mo is the amount of initial material 
(maximum), T is the delay time, P is a shape parameter and a is a time parameter. 
P = 1 means first-order kinetics in the dissolution process. P < 1 means that fast liberation can be 
observed at the beginning of the process, followed by a slower release of active agent. If/?> 1, a 
sigmoidal curve can be seen, indicating that a slow release is followed by faster dissolution. 
Linearized regression from parameters P and a without T gives 
M 
In I n — — — = p-lnt-lna (6) 
M0 -M 
where P is the slope and In a is the intercept. 
After the transformation according to Langenbucher, we obtain 
lntf = /?ln/63.2%, fe.2% = 10"^ (7) 
where U3.2% (min) is the characteristic dissolution time. 
H. MATERIALS AND METHODS 
I. Materials 
Metronidazole (Ph. Eur. 3rd) is a drug frequently used in the treatment of various anaerobic 
infections. It is well absorbed following oral administration. The drug is a useful prophylactic in 
obstetrical and gynaecological interventions, colorectal surgery and appendectomy [87, 88]. Its 
single oral dose is generally 250 mg, and the tablets have a high active agent content. The drug 
and its actions (doses) have been discussed in various papers [89-96]. 
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Microcrystalline cellulose (Avicel PH 101; FMC Corp., Philadelphia, USA) is water-insoluble, 
has a high binding capability and facilitates the compression of other excipients [97], It exhibits a 
low Young's modulus [98] and may be classified as ductile rather than brittle [99,100]. 
Povidone® K-30 (ISP, Belgium) is used in a variety of pharmaceutical formulations, primarily in 
solid dosage forms. In tabletting, Povidone solutions are used as binders in wet granulation 
processes. They may also be used as coating agents. As a binder, tablet diluent or coating agent, 
its useful concentration is 0.5-5.0%(w/w). It is very hygroscopic, significant amounts of moisture 
being absorbed at low relative humidity. The dynamic viscosity of aqueous Povidone solutions 
depends on both the concentration and the molecular weight of the polymer employed [101-105], 
Cross-linked povidone (Kollidon® CL; BASF AG, Germany) is a fine granular powder with 
good flow characteristics. It is a superdisintegrant, used in the tabletting process in a 
concentration of 2-5%(w/w). The disintegration effect is due to the large capillary activity. Its 
water-uptake ability is fairly high [106, 107], The resulting swelling pressure force breaks up the 
tablets. 
Magnesium stearate (Ph. Eur. 3rd) 0.5%(w/w) was applied as a lubricant in the present work. 
This material was chosen because it is probably the most widely used lubricant [108] and is 
known to have excellent lubricating and good anti-adherent properties. However, it exhibits little 
glidant action [109]. 
Cellulose ethers [Hydroxyethyl cellulose (Cellulose WP 4400 L; Union Carbide Belgium N. V.); 
Hydroxypropyl cellulose (Klucel LF; Hercules Inc., USA); Hydroxypropyl methylcellulose 
(Pharmacoat 603; ShinEtsu Chemical Co., Ltd., Japan) or Methylhydroxy ethylcellulose (Tylose 
MH 1000 P; Hoechst AG., Germany)] are used as binders in tablet making involving wet 
granulation [110-112], Increases in the molecular mass and degree of substitution increase the 
viscosity of their aqueous solutions. These solutions belong among the non-Newtonian fluids 
[113], Their water uptake is good and they can retain the water. This ability can be utilized veiy 
well to ensure the optimum moisture content of tablets [114-116], They display surface activity 
and can promote the dissolution of the drug from the tablets [117, 118], They can also be used as 
coating materials [119-121], They can increase the cohesion between the particles and provide the 
tablets with a good hardness. 
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Starches [Corn starch (Ph. Eur. 3rd) and Wheat starch (Roquette, France)] are used as excipients 
primarily in oral solid dosage formulations, where they are utilized as binders, diluents and 
disintegrants. In tablet formulations, freshly prepared starch mucilage is used at a concentration of 
5-25%(w/w) in the granulation prior to tabletting as a binder. Starch is one of the most commonly 
used tablet disintegrants at concentrations of 3-15%(w/w) [122-126]. 
2. Methods 
2.1. Processes 
2.1.1. Homogenization 
Powder mixing was carried out with a Turbula mixer (Willy A. Bachofen Maschinenfabrik, Basel, 
Switzerland) at 50 rpm for 10 min. 
Blending of dry granules with an external phase (magnesium stearate) was performed at 50 rpm 
for 2 min with a Turbula mixer (Willy A. Bachofen Maschinenfabrik, Basel, Switzerland). 
2.1.2. Granulation 
Two methods were used: conventional granulation and fluid bed granulation. 
In conventional granulation, the ingredients of the granules were blended in a high-speed 
mixer (Keripar, Tatabánya, Hungary) for 2 min. After addition of the binder solution, agitation 
was continued for 45 s, the period depending on the consistency of the mass. The wet mass was 
passed through a sieve with a mesh size of 1.2 mm. The granules were dried at room temperature 
to a moisture content of about 1.0% [127], 
In some of the experiments, granulation was performed by means of a fluid-bed apparatus 
(Strea-1, Niro-Aeromatic AG., Switzerland) with the following parameters: 
atomizing pressure: 2.0 bar, 
blow-out pressure: 4.5-5.0 bar, 
drying temperature: 60 °C, 
outlet temperature: 40 °C, 
peripump speed: 30-40 rpm (10-12 ml/min), 
nozzle: 0.8 mm, 
duration of process: 30-40 min. 
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2.1.3. Tabletting 
Tabletting was carried out with a Korsch EKO instrumented eccentric tablet machine (E. Korsch 
Maschinenfabrik, Berlin, Germany) equipped with strain gauges. A displacement transducer was 
applied. 
Tabletting parameters: 
punches: flat, simple, 10 mm in diameter, 
pressure force: 10±2 kN and 15±2 kN, 
relative air humidity: 25-35%, 
air temperature: 24-27 °C, 
rate of pressing: 36 tablets/min, 
compressed quantity: 500 tablets, 
temperature of the table of the tabletting machine: 
2.2. Test methods 
2.2.1. Morphological investigations 
2.2.1.1. Particle shape and surface structure 
Metronidazole crystals and granules and the texture of the tablets were investigated. A Hitachi 
S2400 scanning electron microscope (SEM) (Hitachi Scientific Instruments Ltd., Tokyo, Japan) 
was used. A polaron sputter coating apparatus (Polaron Equipment Ltd., Greenhill, UK) was 
applied to create electric conductivity on the surface of the sample. The air pressure was 1.3-13.0 
mPa [128], 
2.2.1.2. Particle size analysis and distribution 
The above-mentioned materials were investigated. A sample of a few milligrams was dispersed in 
liquid paraffin for deaggregation, and the suspension was then spread on a slide and tested by 
means of a Laborlux S light microscope and a Quantimet 500 (Q500MC) image-processing and 
analysing system (Leica Cambridge Ltd., Cambridge, UK). Particle length, breadth and roundness 
at the start of compression: 
at the end of compression: 
temperature of the tablet: 
25.0-27.6 °C, 
26.1-28.5 °C, 
30-32 °C. 
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(shape parameter) were measured for more than 500 particles each. The obtained data were 
processed statistically by using the Statgraphics package. 
2.2.2. Process of polymer film deformation 
The deformation characteristics of the coating films were studied on free films. 
In my experimental work, 20 g of the granulating solution used for the aggregation was cast in a 
150 mm diameter Petri dish. The dishes were placed on a horizontal surface to ensure an even 
film thickness in every case. The dry films obtained after evaporation of the solvent were kept at 
70% relative humidity during 24 hours until investigation. 
The thickness of the films was measured, after 24 hours, by using a screw micrometer (Mitutoyo, 
Japan; n=20). 
The breaking strength and the deformation process were studied with a modified breaking 
hardness tester (Chinoin Chemical and Pharmaceutical Works Ltd., Budapest, Hungary; see under 
Breaking process). In the test, a piece of the film was fixed in a ring-shaped holder. The process 
of breaking induced by the vertical downward pressure force was observed and the force needed 
to break the film was measured. 
2.2.3. Water uptake determination 
The Enslin number (g/ml) was determined with a glass sieve and a pipette with 0.01 ml accuracy. 
2.2.4. Moisture content 
The moisture contents of granules were measured before tabletting. This was performed 
gravimetrically, through water removal with an infrared lamp mounted on a quick dryer (Szerves 
Vegyipari Vállalat, Budapest, Hungary) [128], A 10 g sample (Wi) was accurately weighed, 
placed under the infrared lamp at 60 °C, and weighed every 10 min until constant weight (W2) 
was attained. The moisture content (MC) was then calculated: 
MC% = ^ • 100 (8) 
Wx 
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2.2.5. Compactibility and rearrangement constant 
The compactibility and the rearrangement constant were tested with a Stampfvolumeter 2003 (J. 
Engelsman AG Apparatebau, Ludwigshafen, Germany) according to a method described in the 
literature [128], The Hausner ratio and Carr's index were obtained. Calx's index was expressed in 
% and considered as the compressibility index related to flowabUity [43], 
The rearrangement constant (k) was calculated from the loose and tapped volume data according 
to Takieddin [46], Linear and exponential regression analysis was subsequently performed, the 
slope of the curve being the rearrangement constant. 
The Kawakita equations were also applied to the data obtained from the tapping test. The volume 
reduction, compactibility and cohesiveness of the investigated materials were evaluated in this 
manner. Tapping tests were performed with 0-200 taps at 10-tap intervals, using the above-
mentioned tap density volumeter. 
2.2.6. Test of granule flowabUity 
Mass by volume 
This was tested with an ASTM apparatus (ASTM D 392-28) according to Ph. Hg. VII and with a 
PTG-1 apparatus (Pharma Test GmbH, Germany). 
Flow properties 
A powder testing apparatus (PTG-1; Pharma Test GmbH, Germany) was used to test the flow 
time and the angle of repose. 
2.2.7. Postcompression tests on tablets 
Geometrical dimension measurements 
The thickness (h) and diameter (D) of the tablets were measured shortly after ejection, and 
remeasured after 24 hours, using a screw micrometer (Mitutoyo Corp., Japan; n=20). 
The percentage elastic recovery (ER%) was calculated by using the equation 
ER% = ~ ^  • 100 (9) 
h 
where h and h2i are the heights of the tablet immediately after ejection and after 24 hours, 
respectively [129], 
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Uniformity of mass 
The tablets were weighed on an analytical balance, with an accuracy of 0.1 mg, and the weight 
variation was calculated («=30 for the tablets). 
Breaking hardness 
The breaking hardness of the tablets was measured 24 hours after ejection on a Heberlein 
apparatus (Heberlein & Co. AG., Switzerland). 
Breaking process 
The breaking process was carried out with a modified breaking hardness tester (Chinoin, 
Chemical and Pharmaceutical Works Ltd., Budapest, Hungary). Its technical parameters: 
range of measurement: 
reading: 
forward rate of pressing jaw: 
recording output: 
sensor: 
accuracy of equipment : 
operating voltage: 
The tablets were positioned vertically. 
0-200N, 
31/2 digits, 
20 mm/min, 
0-500 mV, 
Unicell Load Cell (MHO) 20 kg, 
0.5±0.1 digit, 
220 Vat 50 Hz. 
Friability 
Tablet friability was tested with a Roche friabilator (Erweka Apparatebau GmbH, Heusenstamm, 
Germany). Three lots of 10 tablets were weighed before and after treatment at 100 rpm. The 
results were recorded as the percentage loss from the initial mass. 
Disintegration time 
The disintegration time was determined for 20 individual tablets, using an Erweka VZ4 
disintegration tester (Erweka Apparatebau GmbH, Heusenstamm, Germany). The disintegration 
medium was distilled water at 37±1 °C. 
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Dissolution rate 
The rate of dissolution of metronidazole was studied with a rotary basket method. 
Conditions: 
apparatus: 
dissolution medium: 
temperature: 
rotation speed: 
sampling time: 
number of tablets: 
measurement: 
Pharma Test PTWH, equipped with a rotary basket 
(Pharma Test GmbH, Germany), 
900 ml artifical gastric juice (pH = 1.2 ± 0.1), 
37 ± 0.5 °C, 
50 rpm, 
5,10, 20, 30, 60 and 120 min, 
6, 
at 277 nm with a UV spectrophotometer 
(Spectromom 195D, MOM, Budapest, Hungary). 
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m . RESULTS AND DISCUSSION 
1. Preformulation evaluation 
1.1. Morphological investigations 
The results of the morphological studies of metronidazole crystals are to be seen in Fig. 1. It may 
be stated that metronidazole consists of heterodisperse, stubby columnar crystals. Most of the 
crystals had a length in the range 10-30 pm and a breadth in the range 5-20 pm (Figs 2 and 3). In 
accordance with the roundness values (Table 1), such a crystal shape results in unsuitable flow 
properties. 
Table 1 - Analysis of particle size of metronidazole crystals 
Length Breadth Roundness 
(mm) (mm) 
Average 31.279 18.416 1.427 
Std. 30.624 19.211 0.333 
Minimum 4.154 17.780 1.049 
Maximum 280.000 168.235 3.688 
The roundness is a shape factor providing information on the sphericity of the particles. It is 
calculated by the image analysis software according to the following formula: 
Roundness = ^ ^ (10) 
Aji -area 1.064 
The perimeter is calculated from the horizontal and vertical projections with an allowance for the 
number of corners. The adjustment factor of 1.064 corrects the perimeter for the effect of the 
corners produced by the digitizing of the image [130], 
Several papers are to be found on the determination of the shape factor [131, 132]. The shape 
factor influences the flowability of the materials, and is therefore an important parameter. If its 
value is close to 1, the particles are close to spherical. The shape can be observed from the SEM 
images, but the degree of sphericity can be obtained only by calculating this parameter. 
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Fig. 1 Metronidazole crystals (SEM) 
Fig. 2 
Particle size distribution of metronidazole crystals by length 
Frequency (%) 
0-10 51-60 101-110 151-160 
Size (jum) 
Fig. 3 
Particle size distribution of metronidazole crystals by breadth 
0-5 20- 40- 60- 80- 100- 120-
25 45 65 85 105 125 
Size (¡am) 
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1.2. Process of polymer film deformation 
The investigation of films involved determination of the thickness of the films formed from 
different granulating fluids, study of the deformation process and measurement of the breaking 
strain force. All films had similar force - time curves (Fig. 4). The initial linear change in the force 
indicated elastic behaviour. The force then became constant, in spite of the increasing load, due to 
the viscoelastic character of the film caused by the rearrangement of the binding points between 
macromolecules. This was followed by a linear increase section, again indicating elasticity. At a 
given limit, the force suddenly dropped back to zero and the film broke apart. This time course, of 
course, is influenced by the film thickness, so that all deformation tests were preceded by 
thickness measurement. The outcome of these tests is summarized in Table 2. 
Table 2 - Parameters of the process of deformation of free films 
Thickness Breaking Time of visco- Time of Time of 
Polymers force elastic phase elastic phase breaking 
(mm) (N) (s) (s) (s) 
Klucel LF(10%) 0.117 13.20 1.63 10.05 11.68 
Cellosize WP 4400 L (1%) 0.028 13.10 1.64 10.59 12.23 
Pharmacoat 603 (2%) 0.022 13.21 1.61 6.88 8.49 
Tylose MH 1000 P (2%) 0.025 8.81 1.20 3.05 4.25 
It may be seen that Klucel LF films, made of 10% mucilage, proved to be the thickest. In spite of 
the differences in thickness, the breaking force was the same for films made of Klucel LF, 
Cellosize WP 4400 L or Pharmacoat 603. In contrast, the ultimate stress of Tylose MH 1000 P 
films was lower (Fig. 4). The length of the viscoelastic segment was identical for all three films, 
but the subsequent elastic segment was shorter for the film of Pharmacoat 603, so that this film 
failed earlier. For Klucel LF and Cellosize WP 4400 L films, the elastic deformation lasted equally 
long; in spite of the difference in thickness, therefore, the elasticity of these films was sufficient, 
i.e. they show sufficient elastic recovery after being compressed. All the same, there was a 
difference in the hardness of the tablets, indicating that the film thickness can be of importance in 
the formation of appropriate binding forces. 
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Fig. 4 
Deformation process of Tylose-film 
1. differential curve; 2. deformation curve; 3. integral curve 
2. Influence of Povidone K-30 on the properties of granules and tablets 
Different Povidone products are very frequently used in tablet making. Therefore, for the first part 
of the experimental work, Povidone K-30 was chosen from among the numerous binding agents 
described in the literature. With the use of this binder, granulates were manufactured traditionally 
by kneading and by means of the fluid-bed granulator Strea-1 (see next point). I tried to optimize 
the physico-chemical characteristics of the tablets produced by altering the natures and amounts 
of the binders and other auxiliary components. 
The compositions of the tablets are presented in Table 3. 
Table 3 - Compositions of the tablets 
Components Prep. 1 Prep. 2 Prep. 3 Prep. 4 prep. 5 Prep. 6 Prep. 7 Prep. 8 Prep. 9 Prep. 10 
(mg) (mg) (mg) (mg) (mg) (mg) (mg) (mg) (mg) (mg) 
Metronidazole 250.0 250.0 250.0 250.0 250.0 250.0 250.0 250.0 250.0 250.0 
Cornstarch 80.0 80.0 — 10.0 — 10.0 — — — — 
Wheat starch — — — — 10.0 — — — — — 
KollidonCL — — 15.0 5.0 5.0 5.0 5.0 5.0 5.0 7.0 
Avicel PH 101 10.0 10.0 10.0 10.0 10.0 20.0 20.0 30.0 33.0 33.0 
Povidone K-30 23.2 19.7 7.9 7.6 8.4 7.95 8.3 7.7 10.1 10.1 
Mg-stearate 2.8 2.3 2.1 2.4 2.6 2.05 2.7 2.3 1.9 1.9 
Average mass 366.0 362.0 285.0 285.0 286.0 295.0 286.0 295.0 300.0 302.0 
A morphological investigation of the granules produced was performed first. The crystal shape of 
metronidazole results in unsuitable flow properties (Table 4), but the shape of the granules 
ensured better flowability (Table 4). The granules produced conventionally consist of large 
particles (Fig. 5). Adhering crystals can be observed in each granule particle. The flow properties 
of the active agent and the granules themselves are of primary importance in tabletting, as is the 
size distribution of the granulate produced (see Table 4 for the results). 
The data indicate that it was possible to reduce the flow-out time of the active agent substantially. 
The values of the angle of repose are acceptable and exhibit a narrow distribution. The angle is 
the largest for Preparation 7; the interparticle adhesion is thus the strongest here, but it can be 
reduced by adding a glidant (e.g. Aerosil at 0.2%). As shown by the data, Preparation 3 had the 
highest bulk density, and hence the best space filling. The Hausner factor and Carr's index were 
excellent for all preparations and much better than those of the untreated active agent. 
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Fig. 5 Conventional granule (SEM) 
Table 4 - Flow properties of the granules 
Preparations Moisture content Mass by volume Flowing time Angle of repose Hausner Carr's index 
(%) (g/100 ml) (s) (°) factor (%) 
Metronidazole — 65 23 37.3 1.153 13.334 
Preparation 1 3.7 50 12 36.8 1.045 6.842 
Preparation 2 0.8 44 10 37.7 1.073 6.833 
Preparation 3 0.6 56 9 36.0 1.036 3.498 
Preparation 4 0.5 49 12 37.3 1.060 5.670 
Preparation 5 0.5 49 12 37.7 1.069 6.498 
Preparation 6 1.0 50 10 35.2 1.065 6.173 
Preparation 7 0.7 47 11 37.8 1.069 6.499 
Preparation 8 1.0 49 9 35.6 1.065 6.168 
Preparation 9 0.9 54 9 36.4 1.065 6.166 
Preparation 10 1.0 55 10 35.6 1.063 6.003 
The particle size distribution (Table 5) showed that the majority (55-70%) of the granules were in 
the range 0.32-1.20 mm, but it can be seen that use of a binder agent in higher amount resulted in 
much larger particles (1.2-2.0 mm). In spite of this, the size distribution was suitable for 
tabletting. 
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Table 5 - Particle size distribution of the granules 
Particle size 
Preparations (mm) 
2.0-1.2 1.2-0.8 0.8-0.32 <0.32 
(%) (%) (%) (%) 
Preparation 1 21 20 55 3 
Preparation 2 15 20 50 14 
Preparation 3 19 61 15 5 
Preparation 4 46 20 31 2 
Preparation 5 32 17 46 3 
Preparation 6 6 22 67 4 
Preparation 7 22 31 43 3 
Preparation 8 4 17 69 9 
Preparation 9 32 14 41 12 
Preparation 10 28 17 47 7 
The physical parameters of the tablets are displayed in Table 6. 
Table 6 - Physical parameters of the tablets 
Uniformity of mass Breaking Friability Disintegration 
Preparations hardness time 
(n?g) (N) (%) (s) 
Average SD 
Preparation 1 362.6 2.5 68 1.11 445 
Preparation 2 354.4 4.1 40 1.79 49 
Preparation 3 284.0 1.6 34 1.97 17 
Preparation 4 287.7 3.6 47 1.75 158 
Preparations 28S.6 2.3 34 1.83 28 
Preparation 6 289.2 3.4 43 1.45 49 
Preparation? 279.4 6.6 47 1.36 184 
Preparation 8 290.2 2.0 38 1.52 65 
Preparation 9 307.1 3.3 73 0.97 621 
Preparation 10 300.2 " 3.1 56 1.06 315 
The data reveal that the dosage accuracy was in all cases within the limit set in Ph.Hg.VII [133], 
Preparation 3 had the best dosage accuracy. The uniform space filling was probably due to the 
even spread of the binding agent resulting in more compact and approximately isometric granules. 
The mechanical resistance of the tablets met the requirements in Ph.Hg.VII in every case. The 
friability was below 2%. The disintegration time was within 15 min, also meeting Ph.Hg.VH. It is 
very interesting to observe the changes in the volume of the tablets (Table 7) during 24 hours 
following compression, which are due to the rearrangement of the binding forces. As may be seen 
in Table 7, the diameter of the tablets decreased and their height increased in 24 hours. 
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Table 7 - Geometrical parameters of the tablets 
Geometry Change in geometry Change in 
Preparations After compression After 24 hours volume 
Diameter Thickness Diameter Thickness Diameter Thickness 
(mm) (mm) (mm) (mm) (mm) (mm) (mm3) 
Preparation 1 10.0834 3.6879 10.0810 3.6881 -0.0024 0.0002 -0.12 
Preparation 2 10.1119 3.5802 10.1105 3.5880 -0.0014 0.0078 0.54 
Preparation 3 10.1042 3.0277 10.1023 3.0301 -0.0019 0.0024 0.10 
Preparation 4 10.0949 3.0362 10.0920 3.0371 -0.0029 0.0009 -0.07 
Preparation 5 10.0932 3.0229 10.0917 3.0305 -0.0015 0.0076 0.53 
Preparation 6 10.0968 3.0431 10.0922 3.0451 -0.0046 0.0020 -0.07 
Preparation 7 10.0875 2.9409 10.0814 2.9479 -0.0061 0.0070 0.28 
Preparation 8 10.0862 3.2536 10.0839 3.2673 -0.0023 0.0137 0.98 
Preparation 9 10.0828 3.1767 10.0718 3.1801 -0.0110 0.0034 -0.28 
Preparation 10 10.0928 3.1478 10.0911 3.1532 -0.0017 0.0054 0.35 
One of the most important postcompression tests was the determination of drug liberation. The 
longest dissolution time was that for the tablets prepared with the highest amount of binder. The 
tablets with the best physical parameters were chosen for the drug liberation test. As 
demonstrated in Fig. 6, only 60-70% of the agent was dissolved within 60 min. The likely 
explanation is that, although the disintegration of the tablets is fast, the granules set free failed to 
fall apart rapidly, which could impede appropriate liberation of the pharmacon. 
Fig. 6 Dissolution of metronidazole from the tablets (Preparation 9) 
Dissolved drug 
(%) 
Time (min) 
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3. Influence of the methods on the properties of granules and tablets 
New preparations were prepared in order to investigate the effects of the mode of granulation on 
the properties of the granules and tablets. The compositions were the same (Table 8), but the 
methods were different. One composition was made by kneading, and the other by fluid-bed 
granulation. 
Table 8 lists the compositions of the tablets. The flow parameters demonstrated that, with the 
exception of the angle of repose, all the parameters were improved as compared with those of 
metronidazole alone. The bulk density and flow time were decreased. The angle of repose was 
increased a little in the case of Preparation 11/B and decreased in the case of Preparation 11/A 
(Table 9). 
Table 8 - Composition of the tablets 
Pressure force: 15 kN 
Components Mass 
(mg) 
Metronidazole 250.00 
Avicel PH 101 33.00 
Kollidon CL 7.00* 
Povidone K-30 23.20 
Mg-stearate 1.80 
Average mass 315.00 
*5.00 mg in the internal phase 
*2.00 mg in the external phase 
Table 9 - Flow properties of the granules 
Flowing Mass by Angle of Hausner factor Carr's index 
Preparations time volume repose 
(s) (g/100 ml) n (%) 
Metronidazole 23 65 37.3° 1.153 13.334 
Preparation 11/A 10 47 33.7° 1.071 6.676 
Preparation 11/B 10 37 39.6° 1.048 4.665 
A means fluid bed granulation 
B means conventional granulation 
The reason for this lies in the particle size and shape. The granules prepared by kneading consist 
of larger particles (Fig. 5) and the fluidization granules of smaller particles (Fig. 7), but the 
sphericity of the conventional granules is better and therefore so is their flowability. This 
26 
parameter can be corrected by the use of a glidant. The value for the material prepared by 
kneading is suitable, and thus the use of a glidant is not necessary. 
Fig. 7 Fluid bed granule (SEM) 
The data on the postcompressional parameters of the tablets are presented in Table 10. The 
uniformity of mass is in every case within the limits set by Ph.Hg. VII. 
Table 10 - Physical parameters of the tablets 
Preparations 
Uniformity of mass 
(mg) 
Average SD 
Breaking 
hardness 
(N) 
Dizintegration 
time 
(min) 
Friability 
(%) 
Preparation 11/A 302.4 6.1 80 <15 1.04 
Preparation 11/B 313.1 2.0 54 <15 1.16 
It can be seen that this value was better for Preparation 11/B, prepared with the Strea-1 fluid-bed 
apparatus, but the hardness of the tablets was better for Preparation 11/A, prepared by the 
conventional method, than for Preparation 11/B. This was in accordance with the friability results. 
The disintegration time of the tablets was too long: more than 15 minutes. It can be observed Fig. 
8 that the dissolution of the drug was slow and uniform. It can further be seen that the dissolution 
curve profiles are the same, but more drug could be dissolved from the Preparation 11/B tablet. 
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Fig. 8 Dissolution of metronidazole from the tablets 
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Several papers and monographs deal with the mathematical description of drug liberation [77, 
78], 
The dissolution process was evaluated mathematically via the RRSBW distribution, and the 
characteristic dissolution time (t63.2%) was determined after linearized regression and 
transformation according to Langenbucher. Regression analysis was carried out with the 
Statgraphics package (© STSC, Inc. and Statistical Graphics Co., USA); the confidence limit was 
95%. 
The results are presented in Table 11. The data show that the characteristic dissolution time was 
shorter for the Preparation 11/B tablet, due to its lower hardness. The solid bridges can break 
more easily and the drug can be released more quickly. On the basis of the shape parameter (/?), it 
can be concluded that an exponential process is involved, i.e. a fast drug release is followed by a 
slow saturating process. 
Table 11 - Mathematical evaluation of drug release 
tö3 .2% Slope Intercept Correlation coeffitient 
Peparations (min) (ß) (In a) (R) 
p<0.05 
Preparation 11/A 106.95 0.7080 -3.3084 0.9949 
Preparation 11/B 45.63 0.7441 -2.8429 0.9977 
The data indicate that the same amount of binder resulted in harder tablets with a slower drug 
release following kneading granulation. This means that the two methods require different binder 
contents. 
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4. Influence of cellulose derivatives on the properties of granules and tablets 
In wet granulation, the adequate wetting of the powder mixture is crucial, as this influences the 
uptake of the granulating fluid and hence the formation of a mass of suitable consistency and the 
binding forces themselves. In my experimental work, the water-absorbing capacities of the drug, 
the auxiliaries and the granulates produced by using cellulose ethers were determined. Figure 9 
reveals that the water uptake of metronidazole is rather poor, and it can be potentially improved 
by means of additives with a better water-uptake capacity (e.g. Avicel PH 101 or Kollidon CL). 
Figure 9 also shows the water-absorbing capacities of the different compositions which were 
suitable for wet granulation. 
Time (s) 
Fig. 9 Water uptake of materials and granules 
Enslin number 
(ml/g) 
• Metronidazole 
• Kollidon CL 
• Avicel PH 101 
• Preparation 12 
• Preparation 13 
01 Preparation 14 
• Preparation 15 
The compositions of the tablets are presented in Table 12. The fluid-bed apparatus was used for 
the preparation of the granules. The flow parameters of these granules are presented in Table 13. 
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Table 12 - Compositions of the tablets 
Components Preparation 12 
(mg) 
Preparation 13 
(mg) 
Preparation 14 
(mg) 
Preparation 15 
(mg) 
Metronidazole 250.00 250.00 250.00 250.00 
Avicel PH 101 33.00 33.00 33.00 33.00 
Kollidon CL 10.00 10.00 10.00 10.00 
Cellosize 
WP 4400 L 4.35 — — — 
KlucelLF — 13.2 — — 
Pharmacoat 603 — — 3.24 — 
Tylose 
MH 1000 P 3.34 
Magnesium 
stearate 2.65 1.8 1.76 1.66 
Average mass 300.00 308.00 298.00 298.00 
Table 13 - Rheological parameters of the granules 
Flowing time Angle of Mass by Hausner Carr's index 
Preparations repose volume factor 
(s) (°) (g/100 ml) (%) 
Metronidazole 23 37.3 65.0 1.1538 13.3342 
Preparation 12 11 40.6 36.0 1.0525 4.9913 
Preparation 13 11 41.6 28.3 1.0528 5.0172 
Preparation 14 14 39.1 38.0 1.0951 8.6858 
Preparation 15 11 38.6 41.3 1.0416 4.0000 
The flowability of the granules was influenced by the binder used (Table 13). Except for the angle 
of repose, all the parameters were improved as compared with those of metronidazole alone. The 
mass by volume and the flow-out time were decreased. The values of the angle of repose were not 
changed, or even increased a little, but this can be corrected by the application of a glidant before 
tabletting. 
The Hausner factor and Carr's index, calculated from the loose and the tapped density according 
to the literature, revealed excellent compactibility and compressibility after granulation. 
The actual arrangement of the granulate bulk is characterized by the arrangement factor k (Table 
14). 
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Table 14 - The rearrangement constant 
Preparations Linear model (y=ax+b) Exponential model (y=exp[l+kn]) 
R k F R k F 
Metronidazole 0.367 1193.780 5.21 0.963 0.102 233.43 
Preparation 12 0.777 12.820 10.45 0.952 0.140 59.76 
Preparation 13 0.468 3.390 5.28 0.909 0.075 60.15 
Preparation 14 0.578 3.140 5.48 0.967 0.096 116.58 
Preparation 15 0.789 3.739 11.21 0.977 0.077 127.63 
The values of the correlation coefficient showed that the rearrangement followed an exponential 
model. For a linear model, the correlation (R) was very low, but for an exponential model it was 
near 1. The Table also demonstrates that Preparation 12 had the highest k, i.e. the best 
rearrangement. 
A number of experimental parameters were followed during the tabletting step. Of these, the 
considerable temperature increase for the ready tablets (30-32 °C) is of particular importance. The 
friction during compression results in sintering and partial melting, together with hot spots. This 
in turn can influence the texture of the tablets, possibly affecting the physical parameters of the 
tablets and the liberation of the drug [134, 135], Figure 10 depicts the hot spots induced by the 
compression. In Fig. 11, they are presented at higher magnification. 
The physico-chemical parameters of the tablets tested are presented in Table 15. 
Table 15 - Physical parameters of the tablets 
Preparations 
Average mass 
(mg) 
Uniformity of 
mass 
(mg) 
Friability 
(%) 
Breaking 
hardness 
(N) 
Disintegration 
time 
(s) 
Preparation 12 
10 kN 307.9 ±2.9 2.27 29.5 598 
15 kN 311.5 ±3.3 2.73 31.5 380 
Preparation 13 
10 kN 313.6 ±2.5 0.83 107.2 156 
15 kN 312.6 ±2.8 0.80 112.7 190 
Preparation 14 
10 kN 296.1 ±4.0 2.31 22.2 92 
15 kN 295.4 ±6.9 2.18 23.5 92 
Preparation 15 
10 kN 295.0 ±4.9 2.03 24.7 140 
15 kN 297.0 ±3.4 1.77 27.1 106 
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Fig. 10 "Hot spots" on the surface of the tablet (SEM, Preparation 12) 
Fig. 11 "Hot spots" on the surface of the tablet (SEM, Preparation 12) at 
higher magnification 
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It can be seen from the data that the uniformity of mass was in every case within the limits given 
by Ph.Hg.VII. It is clear that this value was best for Preparation 13, prepared with hydroxypropyl 
cellulose (Klucel LF), and the hardness of these tablets was also the best. For other tablets, the 
hardness was too low. A small increase in hardness was observed at higher pressure force only 
for the tablets prepared with hydroxypropyl cellulose (Klucel LF). This was in accordance with 
the friability results. 
The tablets prepared with hydroxyethyl cellulose (Cellosize WP 4400 L) had the longest 
disintegration time. The disintegration time of the tablets compressed at 10 kN was longer. With 
increase of the pressure force, however, the granule particles underwent a higher degree of 
breakage, and the polymer film also broke, resulting in a shorter disintegration time. 
The disintegration of the other tablets occurred at almost the same time (1.5-3.0 min). Increase of 
the pressure force generally had no influence on the parameters of the tablets. 
The dissolution of the drug was very fast (100% within 10-20 min), with the exception of the 
tablets prepared with hydroxyethyl cellulose (Cellosize WP 4400 L) (Figs 12 and 13). The 
dissolution from this tablet was slow and uniform. Here, the disintegration of the tablet was fast, 
but that of the granules was probably not. The polymer film formed from the granulating fluid is 
transformed to a gel, acting as a barrier against the rapid liberation of the active agent and making 
it prolonged. Furthermore, increase of the pressure force had practically no influence on the rate 
of dissolution of the drug. In the fast drug release, the surface activity of the binder film is an 
important factor. It is well known from the literature that the surface activities of aqueous 
solutions of cellulose derivatives differ [117, 118]. A polymer film is formed from the granulating 
solution. This film should dissolve during the process of dissolution and the surface activity of this 
solution influences the dissolution profile. Hydroxyethyl cellulose has the lowest surface activity 
among the cellulose derivatives used. This is the reason for the decrease in the degree of 
dissolution. 
The results of the mathematical evaluation of the dissolution are presented in Table 16. It can be 
seen that the characteristic dissolution time was very short for Preparations 13, 14 and 15. From 
these tablets, 63.2% of the metronidazole was released within 5 min. The correlation coefficient 
was near to 1. On the basis of the shape parameter (/?), it can be supposed that for Preparations 
12 and 14 the release of the drug followed first-order kinetics with 1, but in the other cases 
the dissolution processes were of other exponential types. 
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Fig. 12 
Dissolution of metronidazole from the tablets (Pressure force = 10 kN) 
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Time (min) 
Fig. 13 
Dissolution of metronidazole from the tablets (Pressure force = 15 kN) 
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Table 16 - Mathematical evaluation of drug release 
Correlation 
t63,2% Slope Intercept coefficient 
Preparations (min) <ß) (Ina) ( r ) 
p<0.05 
Preparation 12 
10 kN 26.27 0.9908 -3.2388 0.9941 
15 kN 43.74 0.9438 -3.1883 0.9951 
Preparation 13 
10 kN 4.03 1.3332 -1.8570 0.9879 
15 kN 3.06 1.1238 -1.2561 0.9715 
Preparation 14 
10 kN 3.63 1.0435 -1.3458 0.9832 
15 kN 4.08 1.0562 -1.4850 0.9988 
Preparation 15 
10 kN 4.70 1.3721 -2.1246 0.9196 
15 kN 5.13 1.5396 -2.5185 0.9795 
The breaking parameters of the tablets are presented in Table 17. It can be observed that an 
Table 17 - Breaking parameters of the tablets 
Preparations Breaking force Breaking work Breaking time Breaking factor 
(N) (mJ) (ms) (mJ/N) 
Preparation 12 
10 kN 25.61 2.34 690.0 0.0913 
(SD=4.82) (SD=9.98) (SD=6.4) 
15 kN 24.75 2.10 658.4 0.0848 
(SD=8.01) (SD=10.94) (SD=6.8) 
Preparation 13 
10 kN 121.09 25.48 1483.5 0.2104 
(SD=3.06) (SD=6.41) (SD=2.6) 
15 kN 128.24 28.52 1551.1 0.2223 
(SD=2.17) (SD=4.93) (SD=3.5) 
Preparation 14 
10 kN 19.21 1.63 591.4 0.0848 
(SD=6.73) (SD=12.78) (SD=13.3) 
15 kN 19.48 1.50 558.6 0.0770 
(SD=9.81) (SD=13.20) (SD=8.3) 
Preparation 15 
10 kN 21.96 1.80 608.5 0.0819 
(SD=4.18) (SD=13.88) (SD=10.5) 
15 kN 21.79 1.83 590.3 0.0839 
(SD=4.69) (SD=14.98) (SD=8.3) 
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increase of the pressure force generally had no influence on the breaking parameters. Small 
increases in these parameters were observed at higher pressure force only for the tablets prepared 
with hydroxypropyl cellulose (Klucel LF). It can be stated that the hardness of these tablets was 
the best, i.e. the binding forces were higher inside these tablets. The breaking force and the 
breaking work were therefore higher and the process took a longer time. From these data, a new 
parameter was calculated: the breaking factor. This is the ratio of the breaking work and the 
breaking force [60], The breaking work depends on the slope of the linear section and the time up 
to the completion of breaking, which results from the elastic behaviour of the tablet. The same 
breaking hardness can be measured at different slopes. If the elastic deformation of the tablet lasts 
longer, the slope of the linear section will be lower and the work necessary for breaking can also 
change. If the resistance of the tablet against the load is less, the breaking work will also be less. 
This is manifested in the value of the breaking factor. A comparison of the data on the tablets of 
Preparations 12, 14 and 15, for example, reveals that a lower breaking factor is indicative of a 
lower breaking work. The differences in the breaking factors of Preparations 12, 14 and 15 are 
not significant, but the differences between that of Preparation 13 and those of the other 
Preparations are (p<0.05). The breaking factor is thus a characteristic tablet parameter suitable for 
the comparison of different tablets. 
The breaking process is displayed in Figs 14 and 15. Two types of deformation behaviour may be 
observed. That in Figure 14 illustrates the process of breaking of Preparation 12 tablets. It can be 
learned from the force - time plot that a small resistance in the initial section is followed by a short 
linear section. This indicates the elastic deformation of the tablet. The force could not decline 
sharply at the breaking point, however, because of the plastic deformation of the tablet. The 
breaking processes of the Preparation 14 and Preparation 15 tablets were very similar. 
Figure 15 depicts the other type of breaking process. The tablets were prepared with Klucel LF 
(Preparation 13). The initial section of the force - time curve was similar to that in Figure 14, but 
the linear section was longer here, continuing until a certain limit, where the tablet underwent 
breaking. The break-point was sharp. This force - time curve indicates the elastic deformability of 
the comprimate. 
It can be considered that the surface activity of the Klucel LF film promoted the fast dissolution, 
and its elastic properties ensured the good hardness and breaking behaviour of the tablets. 
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Fig. 14 Breaking process of metronidazole tablets 
Pressure force: 10 kN Binding agent: Cellosize 
Fig. 15 Breaking process of metronidazole tablets 
Pressure force: 10 kN Binding agent: Klucel LF 
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5. Effects of the concentration of the granulating solution on the properties of granules 
and tablets 
In the further part of my experimental work, I investigated how the physico-chemical properties 
of the granulates and tablets are altered by increasing the concentration of the cellulose-ether 
based granulation fluid. 
The compositions of the tablets are presented in Table 18. The granules were prepared in a fluid-
bed apparatus (Strea-1). It can be seen from the data that the binder content decreased in the 
granules prepared with Cellosize WP 4400 L, and it was the same in the case of the granules 
prepared with Tylose MH 1000 P. However, in the case of granules prepared with Pharmacoat 
603, the binder was used in higher amount. 
Table 18 - Compositions of the tablets 
Components Preparation Preparation Preparation Preparation Preparation Preparation 
12 16 14 17 15 18 
(mg) (mg) (mg) (mg) (mg) (mg) 
Metronidazole 250.00 250.00 250.00 250.00 250.00 250.00 
Avicel PH 101 33.00 33.00 33.00 33.00 33.00 33.00 
Kollidon CL 10.00 10.00 10.00 10.00 10.00 10.00 
Binders Cellosize Cellosize Pharmacoat Pharmacoat Tylose MH Tylose MH 
WP 4400 L WP4400L 603 603 1000 P 1000 P 
(1%) (2%) (2%) (4%) (2%) (3%) 
4.35 3.02 3.24 14.5 3.34 3.18 
Magnesium 
steaiate 2.65 1.98 1.76 2.5 1.66 1.82 
Average mass 300.00 298.00 298.00 310.00 298.00 298.00 
The flowabUity of the granules was tested. The results are presented in Table 19. 
Table 19 - Flowability and particle size of the granules 
Flowing Mass by Angle of Particle size Hausner Can's 
Preparations time volume repose (%) factor index 
2.0-1.2 1.2-0.8 0.8-0.32 <0.32 
(s) (g/100 ml) O mm mm mm mm (%) 
Preparation 12 11 36.0 40.6 7 21 56 14 1.05 4.99 
Preparation 16 9 43.5 32.9 22 18 39 19 1.07 6.99 
Preparation 14 14 38.0 39.1 30 15 43 8 1.09 8.68 
Preparation 17 9 41.0 36.0 33 12 44 11 1.09 9.34 
Preparation 15 11 41.3 38.6 17 16 49 17 1.04 4.00 
Preparation 18 10 43.3 36.6 16 9 46 25 1.08 8.00 
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It is observed that the flow-out time was reduced by change of the amount of the binder. The 
values of the angle of repose were in accordance with the former: for a concentrated granulating 
solution, the angle of repose was less, indicating a reduced adhesion between the granules. In 
spite of this, there is a need for the use of a glidant in tablet pressing. It can be seen from the mass 
by volume data that the bulk density, and thus the space-filling, of the granulates varies with the 
amount of the binder. The sieve analysis revealed that the majority (55-70%) of the granules were 
invariably in the range 0.32-1.20 pm, which is positive for tabletting. 
There were no significant differences in the Hausner factor and Carr's index: these were excellent 
in all three compositions. 
After the compression, the physical parameters of the tablets were tested. The data are given in 
Table 20. 
Table 20 - Physical parameters of the tablets 
Uniformity Breaking Friability Disintegration Uniformity Breaking Friability Disintegration 
of mass hardness time of mass hardness time 
Binders (mg) (N) (%) (s) 1 (mg) (N) (%) (s) 
Pressure force: 10 kN Pressure force: 15 kN 
Preparation 12 307.9 30 2.27 598 311.5 32 2.73 380 
(s=2.9) (s=3.3) 
Preparation 16 295.9 32 1.86 655 287.1 30 2.89 359 
(s=3.0) (s=4.7) 
Preparation 14 296.1 22 2.31 92 295.4 24 2.18 92 
(s=4.0) (s=6.9) 
Preparation 17 302.7 23 1.93 295 299.4 33 1.40 460 
(s=3.8) (s=1.5) 
Preparation 13 295.0 25 2.03 140 297.0 27 1.77 106 
(s=4.9) (s=3.4) 
Preparation 18 292.8 28 1.91 219 282.1 31 1.73 208 
(s=2.0) (8=4.3) 
The data demonstrate that an increase in the concentration of the binder resulted in no change in 
the hardness of the tablets. The values of friability are in accordance with this, but the 
disintegration time generally increased. It can be seen that increase of the concentration of the 
binder did not influence the mechanical hardness of the tablets. 
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6. Effects of storage on the characteristics of tablets produced with cellulose derivatives 
In the last part of the experiments, the alterations in the tablets containing cellulose derivatives 
were studied during storage. Tests were performed after storage for 3 and 6 months. The tablets 
were packed in a polyethylene bag. The post-storage measurement data are shown in Table 21. 
Table 21 - Physical parameters of the tablets 
Preparations 
Uniformity of 
mass 
(tag) 
Breaking 
hardness 
(N) 
Friability 
(%) 
Disintegration 
time 
is) 
Uniformity of 
mass 
(mg) 
Breaking 
hardness 
<N) 
Friability 
(%) 
Disintegration 
time 
(s) 
Pi e s s u r e f o r c e : 10 kN Pr e s s u r e f< t r e e : 15 cN 
After compression 
Preparation 12 After 3 months 
After 6 months 
307.96 
319.11 
320.02 
30 
31 
29 
2.27 
2.02 
2.03 
598 
387 
507 
311.51 
319.37 
318.69 
32 
34 
33 
2.73 
2.31 
2.86 
480 
490 
541 
After ejection 
Preparation 13 After 3 months 
After 6 months 
313.64 
322.98 
323.25 
107 
128 
106 
0.83 
0.72 
0.79 
156 
171 
113 
312.63 
314.52 
314.62 
113 
139 
116 
0.80 
0.73 
0.96 
190 
340 
226 
After ejection 
Preparation 14 After 3 months 
After 6 months 
296.13 
295.69 
295.08 
22 
26 
23 
2.31 
2.03 
2.37 
92 
147 
69 
295.45 
293.65 
292.58 
24 
28 
26 
2.18 
2.09 
2.85 
92 
103 
77 
After ejection 
Preparation 15 After 3 months 
After 6 months 
295.01 
295.10 
296.12 
25 
27 
23 
2.03 
1.68 
2.64 
140 
136 
69 
297.01 
287.63 
288.02 
27 
31 
28 
1.77 
1.39 
2.19 
106 
80 
72 
The data indicate no significant difference in the mechanical stability of the 3-months-old or 6-
months-old tablets relative to those of the fresh tablets. At the same time, it is clear that there was 
a slight increase in the hardness of the Preparation 13 tablets. This was probably due to the after-
hardening processes within the tablets, as the rearrangement of the binding mechanisms in the 3 
months subsequent to compression resulted in a more solid inner texture. Table 21 also shows, 
however, that at 6 months a decrease, albeit minimal, in the hardness was measured. The 
explanation for this may be that, in spite of the careful storage, the tablets absorbed some water 
from the environment and therefore lost some mechanical stability. 
There was a fair correspondence between the values of friability loss and disintegration time and 
those of hardness. Table 21 shows that the friability met the requirements of Ph.Hg.VII only in 
the case of the tablets prepared with hydroxypropyl cellulose (Klucel LF). In contrast, the 
disintegration time was always below 15 min and hence acceptable. 
The above finding is supported by the changes in the tablet volume (Tables 22 and 23). In the 
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Table 22 - Change in volume (pressure force: 10 kN) 
Volume Volume Volume Change in Changera Changera 
Preparations after after after volume volume volume 
24 hours 3 months 6 months (a.24 h.-a.3 m.) (a.24 h.-a.6 m.) (a.24 h.-a.6 m.) 
(mm3) (mm3) (mm3) (mm3) (mm3) (%) 
Preparation 12 261.98 263.35 475.20 1.37 213.32 81.38 
Preparation 13 265.83 262.61 578.08 -3.22 312.39 117.46 
Preparation 14 244.41 246.26 731.53 1.85 487.12 199.30 
Preparation 15 246.38 248.79 832.04 2.41 585.66 237.71 
Table 23 - Change in volume (pressure force: 15 kN) 
Volume Volume Volume Changera Changera Changera 
Preparations after after after volume volume volume 
24 hours 3 months 6 months (a.24 h.-a.3 m.) (a.24 h.-a.6 m.) (a.24 h.-a.6 m.) 
(mm3) (mm3) (mm3) (mm3) (mm3) (%) 
Preparation 12 262.57 264.13 331.99 1.56 69.42 26.43 
Preparation 13 253.49 253.23 674.42 -0.26 420.93 166.05 
Preparation 14 242.66 243.92 773.32 1.26 530.66 218.68 
Preparation 15 239.51 242.25 822.32 2.74 582.81 243.33 
tablets prepared with hydroxypropyl cellulose, there was a considerable volume reduction after 3 
months, which is in accordance with the increase in the hardness. In the other tablets, there was 
practically no volume change during 3 months. After 6 months, however, there was an excessive 
increase in the volume, which was manifested in the reduced hardness. This means that the tablets 
should be stored in a well-closed container, protected from the atmospheric humidity. Storage 
influenced the rate of dissolution of the active agent from the tablets as well (Tables 24-27). 
Tables 24-27 - Drug liberation from the tablets 
P r e p a r a t i o n 1 2 
Pressure force: 10 kN | Pressure force: 15 kN 
Time After 24 After 3 After 6 I After 24 After 3 After 6 
(min) hours months months 1 hours months months 
D i s s o l v e d d r u g % ) 
0 
5 16.60 17.42 13.16 1 18.33 13.02 13.77 
10 27.67 27.63 24.24 I 31.64 27.58 27.97 
20 40.29 43.21 41.95 H 43.87 48.23 44.92 
30 53.01 58.53 57.22 I 68.20 60.57 57.57 
60 74.95 79.66 74.91 1 85.13 87.13 75.55 
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P r e p a r a t i o n 1 3 
Pressure force: 10 kN Pressure force: 15 kN 
Time 
(min) 
After 24 
hours 
After 3 
months 
After 6 
months 
After 24 
hours 
After 3 
months 
After 6 
months 
D i s s o 1 v e d r u g % ) 
0 
5 
10 
20 
30 
60 
76.56 
94.19 
100.33 
101.20 
101.51 
80.68 
96.11 
100.27 
101.01 
101.93 
68.68 
91.35 
98.74 
98.75 
98.78 
85.62 
95.22 
100.55 
100.62 
101.46 
67.89 
84.04 
91.39 
94.52 
101.99 
41.49 
83.06 
95.27 
95.33 
96.27 
P r e P a r a t i o n 1 4 
Pressure force: 10 kN | Pressure force: 15 kN 
Time 
(min) 
After 24 
hours 
After 3 
months 
After 6 
months | 
After 24 
hours 
After 3 
months 
After 6 
months 
D i s s o l v e d d r u g % ) 
0 
5 
10 
20 
30 
60 
67.76 
80.98 
92.46 
96.97 
98.55 
73.21 
85.53 
94.45 
98.71 
101.08 
- I 
70.93 
81.53 
83.63 
84.47 
88.69 
71.79 
91.58 
99.07 
99.58 
102.04 
73.67 
88.77 
98.40 
101.51 
102.52 
66.15 
78.11 
78.46 
79.81 
85.65 
P r e p a r a t i o n 1 5 
Pressure force: 10 kN Pressure force: 15 kN 
Time 
(min) 
After 24 
hours 
After 3 
months 
After 6 
months 
After 24 
hours 
After 3 
months 
After 6 
months 
D i s s o 1 v e c d r u g ( % ) 
0 
5 
10 
20 
30 
60 
74.71 
82.80 
96.36 
99.31 
100.92 
72.55 
89.97 
100.58 
101.00 
101.52 
54.15 
68.68 
77.76 
86.15 
87.16 
66.37 
88.54 
100.76 
101.91 
102.67 
65.67 
86.15 
93.03 
100.91 
102.28 
67.35 
84.91 
85.47 
87.47 
87.59 
The data demonstrate that no change can be seen after 3 months, but the liberation of the drug 
decreased after 6 months. 
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IV. SUMMARY 
Metronidazole consists of heterodisperse, stubby columnar crystals. Such a crystal shape results in 
unsuitable flow properties. 
In wet granulation, the adequate wetting of the powder mixture is crucial, as this influences the 
uptake of the granulating fluid and hence the formation of a mass of suitable consistency and of 
the binding forces themselves. 
The water-uptake capacity of metronidazole is rather poor, and must be improved by means of 
additives with a better water-uptake capacity (Avicel PH 101 or Kollidon CL). 
Conventional (kneading) and fluidization methods were used to prepare granules with Povidone 
K-30. It was found that the same amount of binder resulted in harder tablets with slower drug 
release (U3.2% = 45.63 min) when the preparation mode was kneading granulation (t63.2% = 
106.95 min). This means that the two methods require different binder contents. 
Different cellulose derivatives with different surface activities were also chosen as binders. It was 
concluded that the best physical parameters and dissolution were achieved with tablets prepared 
with the use of hydroxypropyl cellulose at a pressure force of 10 kN. 
The tablets should be stored in a well-closed container, protected from the atmospheric humidity. 
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